Concepedia

S.R. David

SD

Statistics

Publications

8

Citations

2K

H-Index

8

Active since

1998

Affiliations

Eli Lilly (United States)(Current)

S.R. David is an author at Eli Lilly (United States) specializing in psychiatry, psychopharmacology, and antipsychotic pharmacology.

Publications per year

1998–2002

8

Publications

8

Olanzapine Versus Placebo in the Treatment of Acute Mania

Mauricio Tohen, T.M. Sanger, Susan L. McElroy et al. · American Journal of Psychiatry · 1999 · 575 citations

Pharmacy, Pharmacotherapy, Psychiatry +10

ACCOUNTING FOR DROPOUT BIAS USING MIXED-EFFECTS MODELS

Craig Mallinckrodt, W. Scott Clark, S.R. David · Journal of Biopharmaceutical Statistics · 2001 · 412 citations

Public Health, Biostatistics, Causal Inference +16

Double-Blind, Placebo-Controlled Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in the Treatment of Acute Agitation in Schizophrenia

Pádraig Wright, Martin Birkett, S.R. David et al. · American Journal of Psychiatry · 2001 · 303 citations

Pharmacy, Pharmacotherapy, Psychiatry +16

A Double-blind, Placebo-Controlled Dose-Response Comparison of Intramuscular Olanzapine and Haloperidol in the Treatment of Acute Agitation in Schizophrenia

Alan Breier, Karena Meehan, Martin Birkett et al. · Archives of General Psychiatry · 2002 · 290 citations

Medicine, Pharmacotherapy, Psychiatry +17

A Double-Blind, Randomized Comparison of the Efficacy and Safety of Intramuscular Injections of Olanzapine, Lorazepam, or Placebo in Treating Acutely Agitated Patients Diagnosed With Bipolar Mania

Karena Meehan, Fan Zhang, S.R. David et al. · Journal of Clinical Psychopharmacology · 2001 · 256 citations

Medicine, Pharmacotherapy, Psychiatry +17

1–5 of 8